Call Options

14 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$239.25 - $280.76 $9.07 Million - $10.6 Million
37,900 Added 116.98%
70,300 $19.5 Million
Q2 2024

Aug 14, 2024

SELL
$235.51 - $267.98 $10.2 Million - $11.6 Million
-43,200 Reduced 57.14%
32,400 $8.1 Million
Q1 2024

May 15, 2024

SELL
$224.58 - $256.19 $3.62 Million - $4.12 Million
-16,100 Reduced 17.56%
75,600 $18.9 Million
Q4 2023

Feb 14, 2024

BUY
$185.1 - $233.13 $6.46 Million - $8.14 Million
34,900 Added 61.44%
91,700 $21.2 Million
Q3 2023

Nov 14, 2023

BUY
$233.08 - $265.59 $2.19 Million - $2.5 Million
9,400 Added 19.83%
56,800 $14.1 Million
Q2 2023

Aug 14, 2023

BUY
$224.99 - $256.14 $7.24 Million - $8.25 Million
32,200 Added 211.84%
47,400 $11.4 Million
Q1 2023

May 15, 2023

BUY
$239.75 - $277.0 $1.87 Million - $2.16 Million
7,800 Added 105.41%
15,200 $3.83 Million
Q4 2022

Feb 14, 2023

SELL
$241.42 - $282.29 $120,710 - $141,145
-500 Reduced 6.33%
7,400 $1.96 Million
Q3 2022

Nov 14, 2022

BUY
$247.06 - $1507.4 $1.95 Million - $11.9 Million
7,900 New
7,900 $2.04 Million
Q1 2020

May 15, 2020

SELL
$121.39 - $169.05 $1.37 Million - $1.91 Million
-11,300 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$133.47 - $153.48 $2.67 Million - $3.07 Million
-20,000 Reduced 63.9%
11,300 $1.73 Million
Q3 2019

Nov 14, 2019

BUY
$135.4 - $146.47 $2.72 Million - $2.94 Million
20,100 Added 179.46%
31,300 $4.52 Million
Q2 2019

Aug 14, 2019

SELL
$124.88 - $143.73 $399,616 - $459,935
-3,200 Reduced 22.22%
11,200 $1.6 Million
Q1 2019

May 15, 2019

BUY
$97.62 - $132.29 $1.41 Million - $1.9 Million
14,400 New
14,400 $1.9 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $168B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.